chartexchange

LIFE
Ethos Technologies Inc. Class A Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:00:28 PM EST
31.96USD-1.782%(-0.58)558,911
Pre-marketNov 19, 2026 8:40:30 AM EST
33.50USD+2.950%(+0.96)
31.88Bid32.02Ask0.14Spread
Loading…
Loading…
Healthcare
Biotechnology
CEO
Sanjay Shukla
HQ
San Diego, CA, USA
Previous Close
$32.54
Beta
1.79
52-Week High
$49.98 2026-11-03
52-Week Low
$9.45 2026-02-12
SMA 50
$37.47
SMA 200
$24.02
Avg. Vol 10D
1.61M
Avg. Vol 30D
1.56M
Avg. Vol 90D
1.49M
Relative Vol
0.36
5.55M
0.4000%
Jul 1, 2019 · 1-for-14 (reverse)
LIFE Profile

atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators. the company's lead candidate, resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component. resolaris is currently in a phase 1b/2 clinical trial in adult patients with facioscapulohumeral muscular dystrophy (fshd); a phase 1b/2 trial in adult patients with limb girdle muscular dystrophy (lgmd) 2b or fshd; and a phase 1b/2 trial in patients with an early onset form of fshd. to protect this pipeline, atyr built an intellectual property estate comprising 70 issued or allowed patents and over 240 pending patent applications that are solely owned or exclusively licensed by atyr. atyr's key programs are currently focused on severe, rare diseases characterized by immune dysregulation

LIFE Performance
PeriodPriceDateChangeBeta
1W33.522026-11-12-4.48%-1.611
1M38.862026-10-19-17.60%1.706
3M32.852026-08-19-2.53%1.687
6M19.082026-05-19+67.82%1.679
1Y16.852026-01-29+90.03%1.792
2Y1.902024-06-04+1585.23%—
5Y8.202021-11-19+290.48%-0.056
LIFE Stock Summary

Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) stock price today is $32.02, and today's volume is 556,158. LIFE is down 1.600% today. The 30 day average volume is 1.56M. LIFE market cap is $2.08B with 65.02M shares outstanding.